Author's Response to Letter to the Editor Regarding “Efficacy and Safety of Once‐Daily Prolonged‐Release Pregabalin for the Treatment of Patients With Diabetic Peripheral Neuropathy: A Randomized, Double‐Blind, Active, and Placebo‐Controlled Trial”

Pain Practice 2026

View at publisher

Authors: Shilpi Dhawan, Amol Bongirwar, Marta Muñoz‐Tudurí, Aman Khanna Romesh, Prakash Harishchandra Kurmi, Rahul Tulshidas Jankar

DOI: 10.1111/papr.70126

Cited by: 0

References: 6

Fields of Study & Subjects

Pain Mechanisms and Treatments Cancer Treatment and Pharmacology Peripheral Neuropathies and Disorders

References 6